Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.

BACKGROUND A study was performed to evaluate the suitability of stored EDTA-treated control whole blood for use in the preparation of calibration standards and quality control samples for quantitative bioanalytical methods employing dried blood spot (DBS) samples to support pharmaceutical exposure studies. RESULTS It has been demonstrated that a storage time of 14 days for control human and animal blood is suitable for producing quantitative analytical results within internationally recognised acceptance criteria for two analytes. Furthermore, blood hemolysis and chill-thaw cycles have been evaluated and shown not to affect bioanalytical results notably. Aggressive mixing techniques can result in rat blood coagulation; however, this does not occur with other species tested and can be affected by the method of blood collection. CONCLUSION Control whole blood handled and stored using the recommendations generated from this study will not notably affect quantitative bioanalytical results when used for the preparation of calibration standards and quality control samples for DBS assays. It was demonstrated that control human and animal blood can be stored for periods long enough to effectively eliminate wastage.

[1]  Neil Spooner,et al.  The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. , 2010, Bioanalysis.

[2]  Wenkui Li,et al.  Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. , 2010, Biomedical chromatography : BMC.

[3]  L. Stolk,et al.  Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls , 2009, Therapeutic drug monitoring.

[4]  M. Barfield,et al.  Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  M. Barfield,et al.  Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. , 2009, Analytical chemistry.

[6]  Neil Spooner,et al.  Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  J. Hooff,et al.  Therapeutic drug monitoring of tacrolimus with the dried blood spot method. , 2007, Journal of pharmaceutical and biomedical analysis.

[8]  J. Le bras,et al.  Simultaneous determination of monodesethylchloroquine, chloroquine, cycloguanil and proguanil on dried blood spots by reverse-phase liquid chromatography. , 2007, Journal of pharmaceutical and biomedical analysis.

[9]  J. McElnay,et al.  Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  K. Resch,et al.  Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[11]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.